Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
An HIVer's social and economic status can be used to determine how effective antiretroviral treatment will be during initial therapy, according to a study published in the August issue of the Journal of Psychosomatic Research. The effect has even been found among subjects with high rates of drug adherence. Researchers in the study--conducted by a team from Harvard School of Public Health, Massachusetts General Hospital, Stanford University Medical School, and the American Psychological Association--used data from a clinical trial that recruited HIV-positive men and women in the United States and Italy who had not previously taken any anti-HIV medications. The study participants were then treated with combination antiretroviral therapy. Experts have previously suggested that stress and emotional distress predict a faster decline in the immune system cells that can fight HIV's progression. Previous studies have also shown that people at lower socioeconomic positions often report chronic stresses in life. The researchers in this study wanted to examine whether socioeconomic position, based on education level, would influence immune functioning and response to antiretroviral treatments--even if patients adhered to their antiretroviral drugs. The study's authors documented the length of time until a participant first experienced a regimen failure, meaning that the drug combination failed to maintain low HIV levels in the bloodstream or that anti-HIV meds needed to be changed or stopped. The researchers found that participants with lower levels of education reached initial regimen failure faster than participants with a college- or graduate-level degree. However, participants with high levels of 'adherence self-efficacy,' despite lower education levels, experienced a reduction in initial regimen failure by 15% to 17%. Adherence self-efficacy was described as a coping resource that reflected the strength of the patient's belief in the effectiveness of their medication and their ability to adhere to their treatment regimen. The authors suggest that one reason behind this association might be that coping styles are often associated with better immune functioning in individuals with HIV disease. 'These findings support health promotion programs focusing on psychological and behavioral aspects associated with therapeutic regimens,' says Linda Marc, who led the research project while a doctor of science candidate in the department of Society, Human Development, and Health at Harvard School of Public Health.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Happy national foreskin day!
April 04 2024 1:45 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
Scarlet fever: exploring our fascination with blood
March 13 2024 1:47 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Plus: Featured Video
Latest Stories
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM
Yes, HIV-positive people can safely breastfeed
June 26 2024 12:59 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Court rules to keep PrEP coverage under Obamacare
June 21 2024 5:42 PM
In honor of Juneteenth 2024, meet The Normal Anomaly
June 19 2024 1:39 PM
What is Juneteenth?
June 19 2024 11:30 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Advocacy in action with AIDSWatch
May 09 2024 12:30 PM
The Talk: Thriving with HIV
May 08 2024 10:45 AM
The Talk: What HIV isn’t
May 07 2024 10:48 AM
The Talk: Finding balance with HIV
May 06 2024 10:51 AM
Justice Dept plans to reschedule marijuana as a lower-risk drug
May 03 2024 2:40 PM
The Talk: Starting your journey with HIV
May 03 2024 2:00 PM
Why is a mother’s mental health so important? A doctor explains
May 01 2024 1:38 PM
Walmart to close all of its health care clinics
April 30 2024 12:30 PM
Vampire facial spa infected several women with HIV
April 29 2024 7:26 PM